Abstract Body

Human Papilloma virus (HPV) infection of the anal canal is common in men who have sex with men (MSM), though HIV+ MSM show higher rate of HPV persistence, HPV-related anal dysplasia (squamous intraepithelial lesion, SIL) and anal cancer. Local interferon (IFN) response represents the first line of defense against HPV at the mucosal site. HPV has evolved multiple strategies to evade local IFN response, allowing for chronic infection, onset of anal SIL and, ultimately, anal cancer.

70 HIV+ MSM and 30 HIV- MSM were enrolled. Individuals with detectable plasma HIV RNA (lower limit of detection 37 copies/ml) and/or diagnosis of anal cancer and/or inflammatory bowel disease were excluded. Participants underwent anal HPV test, anal cytology and high resolution anoscopy (HRA). Local interferon response was characterized trough the expression of a wide array of IFN related genes (IFNAR1, IFNAR2, INF?, MxA, ISG15, ISG56, IRF1, IRF7, TLR3, TLR4, TLR8, TLR9, IFN?1-3). Gene expression was evaluated trough Real Time RT-PCR performed on an additional anal brush.

HIV+ and HIV- participants showed similar age (49.2 ± 5 and 48 ± 7; p=0.724). Anal HPV DNA tested positive in 72.2% of HIV+ and 47.6% of HIV- participants (p=0.008). Comparison of local IFN response between HIV+/HPV- and HIV-/HPV- participants showed higher expression of IFNAR1 (p=0.009), IFN? (p=0.021), ISG15 (p=0.047), ISG56 (p=0.08), IRF7 (p=0.004), TLR3 (p=0.03), TLR4 (p=0.001) and TLR8 (p=0.08) in HIV+/HPV- subjects. Among HIV+ participants, HPV+ individuals showed a reduced expression of IFNAR1 (p=0.07), IFN? (p=0.019), ISG15 (p=0.036), ISG56 (p=0.039), TLR3 (p=0.011), TLR4 (p=0.002), TLR8 (p=0.006), TLR9 (p=0.012), IFL?2 (p=0.009) and IFN?3 (p=0.038) in respect to HPV- subjects. Among HIV- participants, expression of IFN related genes was similar between HPV+ and HPV- individuals, with the only exception of IFN? (p=0.053). Expression of IFN related genes was similar between HIV+/HPV+ participants with hr-HPV or low risk-HPV. The same was observed among HIV-/HPV+ participants. In both groups, HIV+/HPV+ and HIV-/HPV+, expression of IFN related genes was similar in the presence or absence of SIL.

In the absence of HPV infection, HIV+ MSM show higher anal IFN related genes expression in respect to HIV- MSM. HPV effectively hijacks anal IFN antiviral response in HIV+ MSM but not in HIV- MSM. Anal IFN related genes expression is not influenced by the presence of hr-HPV or anal SIL.